These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 29170269

  • 1. Feasibility of Brain Atrophy Measurement in Clinical Routine without Prior Standardization of the MRI Protocol: Results from MS-MRIUS, a Longitudinal Observational, Multicenter Real-World Outcome Study in Patients with Relapsing-Remitting MS.
    Zivadinov R, Bergsland N, Korn JR, Dwyer MG, Khan N, Medin J, Price JC, Weinstock-Guttman B, Silva D, MS-MRIUS Study Group.
    AJNR Am J Neuroradiol; 2018 Feb; 39(2):289-295. PubMed ID: 29170269
    [Abstract] [Full Text] [Related]

  • 2. Brain Atrophy Is Associated with Disability Progression in Patients with MS followed in a Clinical Routine.
    Ghione E, Bergsland N, Dwyer MG, Hagemeier J, Jakimovski D, Paunkoski I, Ramasamy DP, Silva D, Carl E, Hojnacki D, Kolb C, Weinstock-Guttman B, Zivadinov R.
    AJNR Am J Neuroradiol; 2018 Dec; 39(12):2237-2242. PubMed ID: 30467212
    [Abstract] [Full Text] [Related]

  • 3. Clinical feasibility of longitudinal lateral ventricular volume measurements on T2-FLAIR across MRI scanner changes.
    Jakimovski D, Zivadinov R, Bergsland N, Ramasamy DP, Hagemeier J, Genovese AV, Hojnacki D, Weinstock-Guttman B, Dwyer MG.
    Neuroimage Clin; 2021 Dec; 29():102554. PubMed ID: 33472143
    [Abstract] [Full Text] [Related]

  • 4. Neurological software tool for reliable atrophy measurement (NeuroSTREAM) of the lateral ventricles on clinical-quality T2-FLAIR MRI scans in multiple sclerosis.
    Dwyer MG, Silva D, Bergsland N, Horakova D, Ramasamy D, Durfee J, Vaneckova M, Havrdova E, Zivadinov R.
    Neuroimage Clin; 2017 Dec; 15():769-779. PubMed ID: 28706852
    [Abstract] [Full Text] [Related]

  • 5. An Observational Study to Assess Brain MRI Change and Disease Progression in Multiple Sclerosis Clinical Practice-The MS-MRIUS Study.
    Zivadinov R, Khan N, Medin J, Christoffersen P, Price J, Korn JR, Bonzani I, Dwyer MG, Bergsland N, Carl E, Silva D, Weinstock-Guttman B.
    J Neuroimaging; 2017 May; 27(3):339-347. PubMed ID: 27918139
    [Abstract] [Full Text] [Related]

  • 6. Disability Improvement Is Associated with Less Brain Atrophy Development in Multiple Sclerosis.
    Ghione E, Bergsland N, Dwyer MG, Hagemeier J, Jakimovski D, Ramasamy DP, Hojnacki D, Lizarraga AA, Kolb C, Eckert S, Weinstock-Guttman B, Zivadinov R.
    AJNR Am J Neuroradiol; 2020 Sep; 41(9):1577-1583. PubMed ID: 32763899
    [Abstract] [Full Text] [Related]

  • 7. Brain atrophy and lesion burden are associated with disability progression in a multiple sclerosis real-world dataset using only T2-FLAIR: The NeuroSTREAM MSBase study.
    Barnett M, Bergsland N, Weinstock-Guttman B, Butzkueven H, Kalincik T, Desmond P, Gaillard F, van Pesch V, Ozakbas S, Rojas JI, Boz C, Altintas A, Wang C, Dwyer MG, Yang S, Jakimovski D, Kyle K, Ramasamy DP, Zivadinov R.
    Neuroimage Clin; 2021 Sep; 32():102802. PubMed ID: 34469848
    [Abstract] [Full Text] [Related]

  • 8. Fingolimod's Impact on MRI Brain Volume Measures in Multiple Sclerosis: Results from MS-MRIUS.
    Zivadinov R, Medin J, Khan N, Korn JR, Bergsland N, Dwyer MG, Chitnis T, Naismith RT, Alvarez E, Kinkel P, Cohan S, Hunter SF, Silva D, Weinstock-Guttman B, MS-MRIUS investigators.
    J Neuroimaging; 2018 Jul; 28(4):399-405. PubMed ID: 29749661
    [Abstract] [Full Text] [Related]

  • 9. A Serial 10-Year Follow-Up Study of Atrophied Brain Lesion Volume and Disability Progression in Patients with Relapsing-Remitting MS.
    Zivadinov R, Horakova D, Bergsland N, Hagemeier J, Ramasamy DP, Uher T, Vaneckova M, Havrdova E, Dwyer MG.
    AJNR Am J Neuroradiol; 2019 Mar; 40(3):446-452. PubMed ID: 30819766
    [Abstract] [Full Text] [Related]

  • 10. Therapy effect on AI-derived thalamic atrophy using clinical routine MRI protocol: A longitudinal, multi-center, propensity-matched multiple sclerosis study.
    Jakimovski D, Silva D, Niels Bergsland, Dwyer MG, Weinstock-Guttman B, Benedict RH, Riolo J, Zivadinov R, DeepGRAI Registry Study group.
    Mult Scler Relat Disord; 2023 Jun; 74():104708. PubMed ID: 37084495
    [Abstract] [Full Text] [Related]

  • 11. Quantifying disease pathology and predicting disease progression in multiple sclerosis with only clinical routine T2-FLAIR MRI.
    Fuchs TA, Dwyer MG, Jakimovski D, Bergsland N, Ramasamy DP, Weinstock-Guttman B, Hb Benedict R, Zivadinov R.
    Neuroimage Clin; 2021 Jun; 31():102705. PubMed ID: 34091352
    [Abstract] [Full Text] [Related]

  • 12. Thalamic atrophy and dysconnectivity are associated with cognitive impairment in a multi-center, clinical routine, real-word study of people with relapsing-remitting multiple sclerosis.
    Zivadinov R, Bergsland N, Jakimovski D, Weinstock-Guttman B, Lorefice L, Schoonheim MM, Morrow SA, Ann Picone M, Pardo G, Zarif M, Gudesblatt M, Nicholas JA, Smith A, Hunter S, Newman S, AbdelRazek MA, Hoti I, Riolo J, Silva D, Fuchs TA, Dwyer MG, Hb Benedict R.
    Neuroimage Clin; 2024 Jun; 42():103609. PubMed ID: 38718640
    [Abstract] [Full Text] [Related]

  • 13. Impact of fingolimod on clinical and magnetic resonance imaging outcomes in routine clinical practice: A retrospective analysis of the multiple sclerosis, clinical and MRI outcomes in the USA (MS-MRIUS) study.
    Zivadinov R, Medin J, Khan N, Korn JR, Chitnis T, Naismith RT, Alvarez E, Dwyer MG, Bergsland N, Carl E, Silva D, Weinstock-Guttman B, MS-MRIUS Study Group.
    Mult Scler Relat Disord; 2019 Jan; 27():65-73. PubMed ID: 30342416
    [Abstract] [Full Text] [Related]

  • 14. Comparison of Multiple Sclerosis Cortical Lesion Types Detected by Multicontrast 3T and 7T MRI.
    Maranzano J, Dadar M, Rudko DA, De Nigris D, Elliott C, Gati JS, Morrow SA, Menon RS, Collins DL, Arnold DL, Narayanan S.
    AJNR Am J Neuroradiol; 2019 Jul; 40(7):1162-1169. PubMed ID: 31221631
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of fingolimod on focal and diffuse damage in patients with relapsing-remitting multiple sclerosis - The "EVOLUTION" study.
    Filippi M, Pagani E, Turrini R, Bartezaghi M, Brescia Morra V, Borriello G, Torri Clerici V, Mirabella M, Pasquali L, Patti F, Totaro R, Gallo P, Rocca MA, Evolution Study Group.
    J Neurol; 2024 Sep; 271(9):6181-6196. PubMed ID: 39073436
    [Abstract] [Full Text] [Related]

  • 17. DeepGRAI (Deep Gray Rating via Artificial Intelligence): Fast, feasible, and clinically relevant thalamic atrophy measurement on clinical quality T2-FLAIR MRI in multiple sclerosis.
    Dwyer M, Lyman C, Ferrari H, Bergsland N, Fuchs TA, Jakimovski D, Schweser F, Weinstock-Guttmann B, Benedict RHB, Riolo J, Silva D, Zivadinov R.
    Neuroimage Clin; 2021 Sep; 30():102652. PubMed ID: 33872992
    [Abstract] [Full Text] [Related]

  • 18. Assessing 'No Evidence of Disease Activity' Status in Patients with Relapsing-Remitting Multiple Sclerosis Receiving Fingolimod in Routine Clinical Practice: A Retrospective Analysis of the Multiple Sclerosis Clinical and Magnetic Resonance Imaging Outcomes in the USA (MS-MRIUS) Study.
    Weinstock-Guttman B, Medin J, Khan N, Korn JR, Lathi E, Silversteen J, Calkwood J, Silva D, Zivadinov R, MS-MRIUS Study Group.
    CNS Drugs; 2018 Jan; 32(1):75-84. PubMed ID: 29270772
    [Abstract] [Full Text] [Related]

  • 19. Accuracy of the Compressed Sensing Accelerated 3D-FLAIR Sequence for the Detection of MS Plaques at 3T.
    Toledano-Massiah S, Sayadi A, de Boer R, Gelderblom J, Mahdjoub R, Gerber S, Zuber M, Zins M, Hodel J.
    AJNR Am J Neuroradiol; 2018 Mar; 39(3):454-458. PubMed ID: 29348137
    [Abstract] [Full Text] [Related]

  • 20. Automatic lesion detection at Multiple Sclerosis patients - Comparison of 2D- and 3D-FLAIR-datasets.
    Seehafer S, Schmill LP, Aludin S, Huhndorf M, Larsen N, Jansen O, Stürner K, Peters S.
    Mult Scler Relat Disord; 2024 Aug; 88():105728. PubMed ID: 38909527
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.